AG002W9W

28721-07-5 | 9-oxo-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide

AG002W9W

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	28721-07-5
Catalog Number	AG002W9W(AGN-PC-04XYYK)
Chemical Name	9-oxo-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide
EC Number	249-188-8
IUPAC Name	5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
InChI	InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)
InChI Key	CTRLABGOLIVAIY-UHFFFAOYSA-N
MDL Number	MFCD00865307
Molecular Formula	C15H12N2O2
Molecular Weight	252.2680
NSC Number	758693
SMILES	O=C(N1C2=CC=CC=C2CC(C3=CC=CC=C31)=O)N
UNII	VZI5B1W380
Synonyms	10,11-dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide, GP 47680, oxcarbazepine, Timox, Trileptal, OXCARBAZEPINE, 28721-07-5, Trileptal, Oxcarbamazepine, Oxcarbazepina, Oxcarbazepinum, KIN-493, GP 47680, GP-47680, Oxcarbazepinum [INN-Latin], Oxcarbazepina [INN-Spanish], 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide, 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide, 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide, UNII-VZI5B1W380, 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide, MLS000084586, EINECS 249-188-8, MFCD00865307, 5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo-, 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-oxo-, CHEMBL1068, SMR000048684, CHEBI:7824, VZI5B1W380, Oxacarbazepine, Timox, CTRLABGOLIVAIY-UHFFFAOYSA-N, NCGC00065934-02, 9-oxo-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide, DSSTox_CID_25703, DSSTox_RID_81075, DSSTox_GSID_45703, W-107033, Oxcarbazepine [INN], Oxcarbazepime, Epilexter, Epliga, Oxtellar XR, Trileptal (TN), CAS-28721-07-5, SR-01000612612, Oxcarbazepin, Oxcarbazepine-d4, HSDB 7524, SPN-804, Oxtellar (TN), Oxcarbazepine [USAN:USP:INN:BAN], OCBZ, Spectrum_001675, Opera_ID_818, AC1L1RCU, regid866068, Spectrum2_000483, Spectrum3_001669, Spectrum4_000634, Spectrum5_001869, O0363, AC1Q6NA8, SCHEMBL35129, BSPBio_003457, KBioGR_001248, KBioSS_002155, cid_34312, MLS000759520, MLS001201742, MLS001424025, MLS006011855, BIDD:GT0078, SPECTRUM1504243, SPBio_000345, GTPL7254, ZINC4724, DTXSID0045703, Oxcarbazepine (JAN/USAN/INN), BDBM34179, KBio2_002155, KBio2_004723, KBio2_007291, KBio3_002677, Oxcarbazepine, analytical standard, 10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide, 10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide, HMS1922H17, HMS2051O04, HMS2090F13, HMS2093E10, HMS2231B12, HMS3369J22, HMS3393O04, HMS3657O11, HMS3713I10, Pharmakon1600-01504243, BB_SC-01874, BCP28260, HY-B0114, Tox21_110983, BBL010789, BG0593, CCG-39509, NSC758693, s1391, STK594696, AKOS005516529, Tox21_110983_1, AC-3483, AN-6739, API0003702, CS-1869, DB00776, GP47680, KS-5197, MCULE-9100100302, NC00088, NSC-758693, Oxcarbazepine, >=98% (HPLC), solid, NCGC00065934-03, NCGC00065934-04, NCGC00065934-05, NCGC00065934-06, AK546650, BC204104, CC-33410, CPD000048684, LS-60365, SAM001246754, SC-16252, ZB000586, SBI-0206772.P001, AB0012847, AB1004555, AM20040094, FT-0630543, SW197468-3, A13943, C07492, D00533, EN300-123538, J10384, W-2542, AB00393017-12, AB00393017-14, AB00393017_15, AB00393017_16, 721O075, C-15585, I06-0072, SR-01000612612-4, SR-01000612612-6, BRD-K04196797-001-12-9, 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepin-5-carboxamide, 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine, 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carbonsaeureamid, 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide #, Oxcarbazepine, European Pharmacopoeia (EP) Reference Standard, 10,11-Dihydro-10-oxo-5H-dibenzo(Z)[b,f]azepine-5-carboxamide, Oxcarbazepine, United States Pharmacopeia (USP) Reference Standard, 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide; Oxacarbazepine, Oxcarbazepine, Pharmaceutical Secondary Standard; Certified Reference Material, 9-oxo-2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide, Oxcarbazepine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Oxcarbazepine-13C6 solution, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material, oxecarb, Oxetol, Oxaleptal (TN), Imidazole salicylate, OX-CBZ, D0QL3P, Oxcarbazepine (USAN/INN), Desitin brand of oxcarbazepine, Novartis brand of oxcarbazepine, C15H12N2O2, CID34312, C15-H12-N2-O2, CS-O-30723, H038, B2279, C036006, C476610, D000078330, 1020719-71-4,

Complexity	382
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	252.09g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	2
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	252.273g/mol
Monoisotopic Mass	252.09g/mol
Rotatable Bond Count	0
Topological Polar Surface Area	63.4A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	1.7

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number